Related Experiment Videos
Haemoglobin A1 in diabetes mellitus
Australian and New Zealand Journal of Medicine
|February 1, 1979
Summary
Glycated hemoglobin (HbA1) measurement is a valuable tool for assessing diabetes control. This rapid method accurately reflects long-term blood sugar levels, distinguishing between controlled and uncontrolled diabetes.
Area of Science:
- Clinical Chemistry
- Endocrinology
- Diabetes Mellitus Research
Background:
- Glycated hemoglobin (HbA1) reflects average blood glucose levels over 6-8 weeks.
- Accurate monitoring is crucial for effective diabetes management and preventing complications.
Purpose of the Study:
- To evaluate the utility of a rapid HbA1 assay in routine hospital laboratory settings.
- To correlate HbA1 levels with glycemic control in diabetic patients.
Main Methods:
- A rapid method was employed for HbA1 measurement in a hospital laboratory.
- HbA1 levels were compared between controlled, uncontrolled, and ketoacidotic diabetic patients.
Main Results:
- Normal HbA1 range established as 5.0-8.5%.
- Uncontrolled diabetics showed significantly elevated HbA1 (up to 20.5%), while controlled patients were within the normal range.
- HbA1 correlated with post-prandial, post-insulin blood sugar in insulin-dependent diabetics (p<0.001).
- HbA1 levels decreased approximately six weeks after improved blood sugar control in ketoacidotic patients.
Conclusions:
- Rapid HbA1 measurement is a reliable and useful adjunct for assessing long-term glycemic control in diabetes.
- The assay effectively differentiates between varying degrees of diabetes control.
- HbA1 monitoring aids in evaluating therapeutic effectiveness over time.